Chronic Heart Disease, also known as coronary artery disease or ischemic heart disease, is a prevalent and serious medical condition that affects the heart's blood vessels. It is characterized by the gradual build-up of plaque within the coronary arteries, which supply oxygen-rich blood to the heart muscle. Over time, this accumulation can narrow or block the arteries, leading to reduced blood flow and oxygen delivery to the heart. Common risk factors for chronic heart disease include high blood pressure, high cholesterol levels, smoking, diabetes, and a sedentary lifestyle. The condition often progresses silently, with symptoms such as chest pain (angina), shortness of breath, and fatigue manifesting as the disease advances. If left untreated, chronic heart disease can result in severe complications, including heart attacks and heart failure. Lifestyle modifications, medications, and in some cases, medical procedures like angioplasty or bypass surgery, are common approaches to manage and alleviate the impact of chronic heart disease. Early detection and proactive management play crucial roles in preventing further complications and improving the overall quality of life for individuals affected by this chronic condition.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India